Feldan Therapeutics Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
39
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$563K
- Investors
-
18
Feldan Therapeutics General Information
Description
Operator of a biopharmaceutical company intended to specialize in the development of treatments based on the intracellular delivery of therapeutics. The company's proprietary technology unlocks the development of a new generation of treatments by giving access to intracellular components beyond the reach of existing drugs, enabling the safe and efficient delivery of various compounds inside cells.
Contact Information
Website
www.feldan.comCorporate Office
- 2666 Boulevard Du Parc Technologique
- Suite 290
- Quebec, Quebec G1P 4S6
- Canada
Corporate Office
- 2666 Boulevard Du Parc Technologique
- Suite 290
- Quebec, Quebec G1P 4S6
- Canada
Feldan Therapeutics Timeline
Feldan Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Grant | 28-Aug-2023 | $563K | 000.00 | Completed | Clinical Trials - Phase 1 | |
| 7. Grant | 26-Jun-2023 | 00000 | 000.00 | Completed | Clinical Trials - Phase 1 | |
| 6. Later Stage VC (Series B) | 13-Jun-2023 | 000.00 | 000.00 | Completed | Clinical Trials - Phase 1 | |
| 5. Later Stage VC (Series A) | 18-Sep-2018 | 000.00 | 000.00 | Completed | Pre-Clinical Trials | |
| 4. Later Stage VC | 01-Apr-2017 | 000 | 00.000 | Completed | Pre-Clinical Trials | |
| 3. Later Stage VC | 05-Oct-2015 | 00.00 | 00.000 | Completed | Pre-Clinical Trials | |
| 2. Accelerator/Incubator | $385K | Completed | Pre-Clinical Trials | |||
| 1. Angel (individual) | 28-Sep-2011 | $385K | $385K | Completed | Pre-Clinical Trials |
Feldan Therapeutics Comparisons
Industry
Financing
Details
000000
000000
Feldan Therapeutics Competitors (9)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Entrada Therapeutics | Formerly VC-backed | Boston, MA | 000 | 00000 | 00000000 | 00000 |
| ProSci (Poway) | Private Equity-Backed | Poway, CA | 00 | 000000000000 | ||
| AiViva BioPharma | Venture Capital-Backed | Costa Mesa, CA | 00 | 0000 | 000000000000 | 0000 |
| Palvella Therapeutics | Venture Capital-Backed | Wayne, PA | 00 | 00000 | 000000000 | 00000 |
| Integrated DNA Technologies | Formerly PE-Backed | Coralville, IA | 0000 | 00000 | 000000&0 | 00000 |
Feldan Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Feldan Therapeutics Executive Team (4)
| Name | Title | Board Seat |
|---|---|---|
| Francois-Thomas Michaud Ph.D | Co-Founder, Chief Executive Officer & Board Member | |
| Vincent Ménard Ph.D | Chief Financial Officer | |
| Kenneth Kobayashi MD | Chief Medical Officer |
Feldan Therapeutics Board Members (19)
| Name | Representing | Role | Since |
|---|---|---|---|
| Angie Chun | GC Cell | Board Member | 000 0000 |
| David Mazzo Ph.D | Self | Chairman | 000 0000 |
| Elisabeth Sandoval Little | Self | Board Member | 000 0000 |
| Francois-Thomas Michaud Ph.D | Feldan Therapeutics | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
| Iain Dukes Ph.D | Self | Board Member | 000 0000 |
Feldan Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Feldan Therapeutics Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Research Council Canada | Government | 000 0000 | 000000 0 | |
| CCI | Corporation | 000 0000 | 000000 0 | |
| Amgen Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |
| CQDM | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 |
| Fonds de solidarite FTQ | PE/Buyout | Minority | 000 0000 | 000000 0 |
Feldan Therapeutics FAQs
-
When was Feldan Therapeutics founded?
Feldan Therapeutics was founded in 2007.
-
Who is the founder of Feldan Therapeutics?
Francois-Eric Lebeau and Francois-Thomas Michaud Ph.D are the founders of Feldan Therapeutics.
-
Who is the CEO of Feldan Therapeutics?
Francois-Thomas Michaud Ph.D is the CEO of Feldan Therapeutics.
-
Where is Feldan Therapeutics headquartered?
Feldan Therapeutics is headquartered in Quebec, Canada.
-
What is the size of Feldan Therapeutics?
Feldan Therapeutics has 39 total employees.
-
What industry is Feldan Therapeutics in?
Feldan Therapeutics’s primary industry is Biotechnology.
-
Is Feldan Therapeutics a private or public company?
Feldan Therapeutics is a Private company.
-
What is Feldan Therapeutics’s current revenue?
The current revenue for Feldan Therapeutics is 000000.
-
How much funding has Feldan Therapeutics raised over time?
Feldan Therapeutics has raised $37.4M.
-
Who are Feldan Therapeutics’s investors?
National Research Council Canada, CCI, Amgen Ventures, CQDM, and Fonds de solidarite FTQ are 5 of 18 investors who have invested in Feldan Therapeutics.
-
Who are Feldan Therapeutics’s competitors?
Entrada Therapeutics, ProSci (Poway), AiViva BioPharma, Palvella Therapeutics, and Integrated DNA Technologies are some of the 9 competitors of Feldan Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
